A detailed history of Northeast Investment Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Northeast Investment Management holds 51,252 shares of LLY stock, worth $40.8 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares
51,252
Previous 50,474 1.54%
Holding current value
$40.8 Million
Previous $45.7 Million 0.64%
% of portfolio
2.08%
Previous 2.2%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $600,724 - $746,895
778 Added 1.54%
51,252 $45.4 Million
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $2.76 Million - $3.46 Million
3,801 Added 8.14%
50,474 $45.7 Million
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $3.17 Million - $4.25 Million
5,361 Added 12.98%
46,673 $36.3 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $2.92 Million - $3.44 Million
5,563 Added 15.56%
41,312 $24.1 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $2.63 Million - $3.62 Million
6,048 Added 20.36%
35,749 $19.2 Million
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $4.43 Million - $5.93 Million
12,643 Added 74.12%
29,701 $13.9 Million
Q1 2023

Apr 28, 2023

BUY
$310.63 - $364.82 $302,864 - $355,699
975 Added 6.06%
17,058 $5.86 Million
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $409,011 - $476,580
1,272 Added 8.59%
16,083 $5.88 Million
Q3 2022

Oct 28, 2022

BUY
$296.48 - $337.87 $411,514 - $468,963
1,388 Added 10.34%
14,811 $4.79 Million
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $522,061 - $612,976
1,873 Added 16.22%
13,423 $4.35 Million
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $416,340 - $517,404
1,774 Added 18.15%
11,550 $3.31 Million
Q4 2021

Feb 07, 2022

SELL
$224.85 - $279.04 $136,259 - $169,098
-606 Reduced 5.84%
9,776 $2.7 Million
Q3 2021

Nov 08, 2021

SELL
$221.6 - $272.71 $6,648 - $8,181
-30 Reduced 0.29%
10,382 $2.4 Million
Q2 2021

Aug 05, 2021

SELL
$180.55 - $233.54 $47,484 - $61,421
-263 Reduced 2.46%
10,412 $2.39 Million
Q1 2021

May 11, 2021

BUY
$164.32 - $212.72 $12,324 - $15,954
75 Added 0.71%
10,675 $1.99 Million
Q4 2020

Feb 10, 2021

SELL
$130.46 - $172.63 $8,479 - $11,220
-65 Reduced 0.61%
10,600 $1.79 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $2,485 - $2,875
-17 Reduced 0.16%
10,665 $1.58 Million
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $12,004 - $14,447
88 Added 0.83%
10,682 $1.75 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $47,024 - $58,203
-395 Reduced 3.59%
10,594 $1.47 Million
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $20,717 - $22,535
-194 Reduced 1.73%
10,989 $1.23 Million
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $18,169 - $21,208
-164 Reduced 1.45%
11,183 $1.24 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $12,466 - $14,674
-112 Reduced 0.98%
11,347 $1.47 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $70,953 - $79,488
-670 Reduced 5.52%
11,459 $1.33 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $2,271 - $2,606
-30 Reduced 0.25%
12,129 $1.04 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $51,204 - $60,443
-690 Reduced 5.37%
12,159 $941,000
Q4 2017

Jan 29, 2018

BUY
$81.94 - $87.89 $11,471 - $12,304
140 Added 1.1%
12,849 $1.09 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $979,482 - $1.09 Million
12,709
12,709 $1.09 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northeast Investment Management Portfolio

Follow Northeast Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.